SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-050721
Filing Date
2020-04-24
Accepted
2020-04-24 09:26:23
Documents
4
Period of Report
2020-06-15
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2016301-1_def14a.htm DEF 14A 778636
2 GRAPHIC sg_jackakhattar-bw.jpg GRAPHIC 157463
3 GRAPHIC tm2016301d1-pc1.jpg GRAPHIC 469854
4 GRAPHIC tm2016301d1-pc2.jpg GRAPHIC 412500
  Complete submission text file 0001104659-20-050721.txt   2194573
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35518 | Film No.: 20812819
SIC: 2834 Pharmaceutical Preparations